Bharat Biotech emphasizes the safety record of its indigenous vaccine Covaxin, highlighting its excellent safety profile and absence of rare side effects like blood clots and thrombocytopenia. The ...
Credit: Peakstock / Shutterstock. Virion Therapeutics has reported encouraging safety outcomes from the first-in-human Phase IB clinical study of VRON-0200, a checkpoint modifier immunotherapy being ...
Bacteriophage N4 minivirion RNA polymerase (mini-vRNAP), the RNA polymerase (RNAP) domain of vRNAP, is a member of the T7-like RNAP family. Mini-vRNAP recognizes promoters that comprise conserved ...